sechenovSechenov Medical JournalСеченовский вестник2218-73322658-3348Сеченовский Университетsechenov-572Research ArticleCLINICAL MEDICINEУСПЕХИ КЛИНИЧЕСКОЙ МЕДИЦИНЫComparative analysis of laser ovarian drilling in surgical management of polycystic ovarian syndromeСравнительная оценка лазерного дриллинга яичников при хирургическом лечении женщин с синдромом поликистозных яичниковАгаджанянЭ. С.AghajanyanE. S.

Агаджанян Элла Сейрановна, старший лаборант кафедры акушерства и гинекологии № 1

119991, г. Москва, ул. Трубецкая, д. 8, стр. 2

Ella S. Aghajanyan, Senior research fellow, Department of Obstetrics and Gynecology № 1

8-2, Trubetskaya, Moscow, 119991

ellaseiranovna@mail.ruИщенкоА. И.IshchenkoA. I.

Доктор медицинских наук, профессор, заведующий кафедрой акушерства и гинекологии № 1

Москва

Doctor of Medical Sciences, Professor, Head of Department of Obstetrics and Gynecology № 1

Moscow

ЗуевВ. М.ZuevV. M.

Доктор медицинских наук, профессор кафедры акушерства и гинекологии № 1

Москва

Doctor of Medical Sciences, Professor, Department of Obstetrics and Gynecology № 1

Moscow

ДжибладзеТ. А.DzhibladzeT. A.

Доктор медицинских наук, профессор кафедры акушерства и гинекологии № 1

Москва

Doctor of Medical Sciences, Professor, Department of Obstetrics and Gynecology № 1

Moscow

ФГБОУ ВО Первый МГМУ имени И.М. Сеченова Минздрава РоссииРоссияI.M. Sechenov First MSMURussian Federation201630122016044652Copyright © Aghajanyan E.S., Ishchenko A.I., Zuev V.M., Dzhibladze T.A., 20162016Агаджанян Э.С., Ищенко А.И., Зуев В.М., Джибладзе Т.А.Aghajanyan E.S., Ishchenko A.I., Zuev V.M., Dzhibladze T.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.sechenovmedj.com/jour/article/view/572

To assess the role of laparoscopic laser ovarian drilling in surgical management of polycystic ovary syndrome (PCOS) in comparison to other surgical techniques. The study involved 60 women diagnosed with polycystic ovary syndrome (clinical symptoms of the disease, as well as pelvic ultrasound scans and serum hormone levels, were assessed before and after surgery). Depending on the type of surgery, all patients were divided into groups: group № 1 (30 patients) underwent laparoscopic laser ovarian drilling using holmium laser, group № 2 (30 patients) underwent laparoscopic ovarian cautery using needle electrode. Group № 1 patients showed significantly higher rate of ovulation recovery and reproductive success in the program of assisted reproductive technologies (ART) when compared to group № 2 patients. When timely referred to the ART program after surgery, PCOS patients have a significantly higher chance of success in attaining and maintaining pregnancy. Ключевые слова. Синдром поликистозных яичников, лазерный дриллинг, гольмиевый лазер, электронож.

В статье дается оценка роли лапароскопического лазерного дриллинга яичников при синдроме поликистозных яичников в сравнении с другими методами оперативного лечения. Обследованы 60 женщин с диагнозом СПКЯ (проведена оценка клинических проявлений заболевания, УЗ-диагностика органов малого таза, определение концентрации гормонов в сыворотке крови до и после оперативного лечения). Все пациентки в зависимости от вида хирургического вмешательства были разделены на две группы: в первой группе (30 женщин) проводился лапароскопический лазерный дриллинг яичников с помощью гольмиевого лазера, во второй группе (30 женщин) – лапароскопическая электрохирургическая каутеризация с помощью игольчатого электрода (электроножа). У пациенток 1-й группы после проведенного лазерного дриллинга процент восстановления овуляторного и репродуктивного потенциала в программе вспомогательных репродуктивных технологий был достоверно выше в сравнении с аналогичным показателем у пациенток 2-й группы. Раннее вступление в программу вспомогательных репродуктивных технологий пациенток с СПКЯ после оперативного лечения повышает шансы наступления беременности.

Синдром поликистозных яичниковлазерный дриллинггольмиевый лазерэлектроножPolycystic ovarian syndromelaser drillingholmium laserelectrotomeReferencesКулаков В.И., Леонов Б.В., Кузьмичев Л.Н. (ред.). Лечение мужского и женского бесплодия. М.: МИА; 2005: 592.Kulakov V.I., Leonova B.V., Kuzmicheva L.N. (eds). Treatment of male and female infertility. Moscow: MIA; 2005: 592 (in Russian).Siristatidis C. et al. In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction 2013. Cochrane Database Syst. Rev. 2013; Oct. 8: 10: CD006606. doi:10.1002/14651858.CD006606. pub 3.Siristatidis C. et al. In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction 2013. Cochrane Database Syst. Rev. 2013; Oct. 8: 10: CD006606. doi:10.1002/14651858.CD006606. pub 3.Sirmans S., Pate K. Epidemiology, diagnosis and management of polycystic ovary syndrome. Clin. Epidemiol. 2013; Dec; 18: 61–13.Sirmans S., Pate K. Epidemiology, diagnosis and management of polycystic ovary syndrome. Clin. Epidemiol. 2013; Dec; 18: 61–13.Drosdzol-Cop A. et al. Diagnosing polycystic ovary syndrome in adolescent girls. Ginekol. Pol. 2014; Feb; 85(2):145–148.Drosdzol-Cop A. et al. Diagnosing polycystic ovary syndrome in adolescent girls. Ginekol. Pol. 2014; Feb; 85(2):145–148.Azziz R. Controversy in clinical endocrinology: diagnosis of polycyctic ovarian syndrome: The Rotterdam criteria are premature. J. Clin. Endocrinol. Metab. 2006; 91: 781–785.Azziz R. Controversy in clinical endocrinology: diagnosis of polycyctic ovarian syndrome: The Rotterdam criteria are premature. J. Clin. Endocrinol. Metab. 2006; 91: 781–785.Norman R.J. et al. Polycyctic ovary syndrome. Lancet. 2007; 370: 685–697.Norman R.J. et al. Polycyctic ovary syndrome. Lancet. 2007; 370: 685–697.Setji T.L., Brown A.J. Polycystic ovary syndrome: update on diagnosis and treatment. Am. J. Med. 2014; May 21: S0002-9343(14)00356-8.Setji T.L., Brown A.J. Polycystic ovary syndrome: update on diagnosis and treatment. Am. J. Med. 2014; May 21: S0002-9343(14)00356-8.Levadas S., Diamanti-Kandarakis E. Polycystic ovary syndrome: definitions, phenotypes and diagnostic approach. Front Horm. Res. 2013; 40: 1–21.Levadas S., Diamanti-Kandarakis E. Polycystic ovary syndrome: definitions, phenotypes and diagnostic approach. Front Horm. Res. 2013; 40: 1–21.Corbett S., Morin-Papunen L. The polycystic Ovary Syndrome and recent human evolution. Mol. Cell Endocrinol. 2013; Jul 5; 373(1–2): 39–50.Corbett S., Morin-Papunen L. The polycystic Ovary Syndrome and recent human evolution. Mol. Cell Endocrinol. 2013; Jul 5; 373(1–2): 39–50.Abu Hashim H., Al-Inany H., De Vos M., Tournaye H. Three decades after Gjonnaess’s laparoscopic ovarian drilling for treatment of PCOS; what do we know? An evidence –based approach. Arch. Gynecol. Obstet. 2013; Aug; 288(2): 409–422.Abu Hashim H., Al-Inany H., De Vos M., Tournaye H. Three decades after Gjonnaess’s laparoscopic ovarian drilling for treatment of PCOS; what do we know? An evidence –based approach. Arch. Gynecol. Obstet. 2013; Aug; 288(2): 409–422.Pellatt L., Hanna L., Brincat M., Galea R., Brain H., Whitehead S., Mason H. Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries. J. Clin. Endocrinol Metab. 2007; Jan; 92(1): 240–245.Pellatt L., Hanna L., Brincat M., Galea R., Brain H., Whitehead S., Mason H. Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries. J. Clin. Endocrinol Metab. 2007; Jan; 92(1): 240–245.Pigny P., Jonard S., Robert Y., Dewailly D. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2006; Mar; 91(3): 941–945.Pigny P., Jonard S., Robert Y., Dewailly D. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2006; Mar; 91(3): 941–945.Pigny P., Merlen E., Robert Y., Cortet-Rudelli C., Decanter C., Jonard S., Dewailly D. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J. Clin. Endocrinol. Metab. 2003; Dec; 88(12): 5957–5962.Pigny P., Merlen E., Robert Y., Cortet-Rudelli C., Decanter C., Jonard S., Dewailly D. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J. Clin. Endocrinol. Metab. 2003; Dec; 88(12): 5957–5962.Huber J., Hosmann J., Spona J. Polycystic ovarian syndrome treated by laser through the laparoscope. Lancet. 1988; 2: 215.Huber J., Hosmann J., Spona J. Polycystic ovarian syndrome treated by laser through the laparoscope. Lancet. 1988; 2: 215.Daniell J.F., Miller W. Polycystic ovaries treated by laparoscopic laser vaporization. Fertil. Steril. 1989; 51: 232–236.Daniell J.F., Miller W. Polycystic ovaries treated by laparoscopic laser vaporization. Fertil. Steril. 1989; 51: 232–236.Van Wely M., Bayram N., van der Veen F., Bossuyt P.M. Predictors for treatment failure after laparoscopic electrocautery of the ovaries in women with clomiphene citrate resistant polycystic ovary syndrome. Hum Reprod. 2012; Dec; 27(12): 3577–82.Van Wely M., Bayram N., van der Veen F., Bossuyt P.M. Predictors for treatment failure after laparoscopic electrocautery of the ovaries in women with clomiphene citrate resistant polycystic ovary syndrome. Hum Reprod. 2012; Dec; 27(12): 3577–82.Cohen J. Laparoscopic procedures for treatment of infertility related to polycystic ovarian syndrome. Hum. Reprod. Update. 1996; 2: 337–344.Cohen J. Laparoscopic procedures for treatment of infertility related to polycystic ovarian syndrome. Hum. Reprod. Update. 1996; 2: 337–344.Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil and Steril. 2004; 81(1): 19–25.Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil and Steril. 2004; 81(1): 19–25.Деркач Д.А., Пономарева Т.А., Карпова Е.А., Андреева Е.Н. Хирургическое лечение ановуляции (обзор литературы). Проблемы репродукции. 2009; 2: 67–72.Derkach D.A., Ponomarev T.A., Karpova E.A., Andreeva E.N. Surgical treatment of anovulation (review). Problems of reproduction. 2009; 2: 67–72 (in Russian).Ищенко А.А., Зуев В.М., Джибладзе Т.А. и др. Применение гольмиевого лазера в оперативной гинекологии : учеб. пособие для интернов и клин. ординаторов. 2008: 3–28.Ishchenko A.I., Zuev V.M., Djibladze T.A. et al. Application of the holmium laser in operative gynecology. In: Textbook for interns and medical residents. 2008: 3–28 (in Russian).Artini P.G. et al. Best methods for identification and treatment of PCOS. Minerva Ginecol. 2010; Feb; 62(1): 33–48.Artini P.G. et al. Best methods for identification and treatment of PCOS. Minerva Ginecol. 2010; Feb; 62(1): 33–48.Palomba S., Falbo A., Russo T., Zullo F. Ovulation induction in anovulatory patients with polycystic ovarian syndrome. Curr. Drug Ther. 2006; 1: 23–29.Palomba S., Falbo A., Russo T., Zullo F. Ovulation induction in anovulatory patients with polycystic ovarian syndrome. Curr. Drug Ther. 2006; 1: 23–29.Sheehan M.T. MD Polycystic Ovarian Syndrome: Diagnosis and Management. Clin. Med. Res. 2004; Feb; 2(1): 13–27.Sheehan M.T. MD Polycystic Ovarian Syndrome: Diagnosis and Management. Clin. Med. Res. 2004; Feb; 2(1): 13–27.Arbo E., Vetori D.V., Jimenez M.F. et al. Serum antimullerian hormone levels and follicular cohort characteristics after pituitary suppression in the late luteal phase with oral contraceptive pills. Human Reproduction. 2007; 22: 3192–3196.Arbo E., Vetori D.V., Jimenez M.F. et al. Serum antimullerian hormone levels and follicular cohort characteristics after pituitary suppression in the late luteal phase with oral contraceptive pills. Human Reproduction. 2007; 22: 3192–3196.Broer S., Mol B.W., Dolleman M. et al. The role of antiMullerian hormone assessment in assisted reproductive technology outcome. Curr. Opin. Obstet. Gynecol. 2010; 22: 193–201.Broer S., Mol B.W., Dolleman M. et al. The role of antiMullerian hormone assessment in assisted reproductive technology outcome. Curr. Opin. Obstet. Gynecol. 2010; 22: 193–201.

The authors declare that there are no conflicts of interest present.